FIGURE

Fig. 4

ID

ZDB-FIG-230224-18

Publication

Sahin et al., 2022 - Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Figure 4. In vitro screening of CNSL derivatives for PPARα, PPARγ, and PPARδ activity reveals a subset of selective pan-activators. HEK293 cells were transiently co-transfected with GAL4-hPPARα (A), GAL4-hPPARγ (B), or GAL4-hPPARδ (C) together with UAS-luciferase reporter and treated with positive controls (10 nM GW7647, 100 nM Rosi, and 10 nM GW0742) or 50 μM of indicated compounds for 16 h. Data represent mean ± standard deviation (SD) (N = 3). RLU, relative luciferase units = luciferase light units/β-galactosidase × time. Vehicle (DMSO) response was set to 1. C10:0, decanoic acid; C14:0, myristic acid; C18:0, stearic acid; C18:1n9, oleic acid. *P < 0.05 relative to corresponding vehicle, using one-way analysis of variance (ANOVA) with Holm–Šidák correction.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J. Med. Chem.